Log in to save to my catalogue

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6584248

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

About this item

Full title

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Publisher

Cham: Springer International Publishing

Journal title

Clinical pharmacokinetics, 2019-07, Vol.58 (7), p.835-857

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Immune checkpoint inhibitors (ICIs) have demonstrated significant clinical impact in improving overall survival of several malignancies associated with poor outcomes; however, only 20–40% of patients will show long-lasting survival. Further clarification of factors related to treatment response can support improvements in clinical outcome and guide...

Alternative Titles

Full title

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6584248

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6584248

Other Identifiers

ISSN

0312-5963

E-ISSN

1179-1926

DOI

10.1007/s40262-019-00748-2

How to access this item